Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Authors: Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao et al.

Year: 2020

Coronavirus disease 2019 (COVID-19)MedicinePlaceboSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreak